Certara is a global leader in biosimulation, providing software and tech-enabled services that have contributed to 90 new drug approvals by the FDA since 2014.
Specializing in model-informed drug development, regulatory science, and market access solutions, Certara serves 2,000 global biopharmaceutical companies, academic institutions, and regulatory agencies in 62 countries.
Generated from their website's infomation